228 related articles for article (PubMed ID: 16849538)
1. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
[TBL] [Abstract][Full Text] [Related]
3. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
Schmidt HH
Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
[No Abstract] [Full Text] [Related]
4. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
[TBL] [Abstract][Full Text] [Related]
6. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
[TBL] [Abstract][Full Text] [Related]
7. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
[TBL] [Abstract][Full Text] [Related]
8. Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases.
Murati A; Gervais C; Carbuccia N; Finetti P; Cervera N; Adélaïde J; Struski S; Lippert E; Mugneret F; Tigaud I; Penther D; Bastard C; Poppe B; Speleman F; Baranger L; Luquet I; Cornillet-Lefebvre P; Nadal N; Nguyen-Khac F; Pérot C; Olschwang S; Bertucci F; Chaffanet M; Lessard M; Mozziconacci MJ; Birnbaum D;
Leukemia; 2009 Jan; 23(1):85-94. PubMed ID: 18818702
[TBL] [Abstract][Full Text] [Related]
9. FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.
Barrett R; Morash B; Roback D; Pambrun C; Marfleet L; Ketterling RP; Harrison K; Berman JN
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097792
[TBL] [Abstract][Full Text] [Related]
10. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.
Murati A; Adélaïde J; Quilichini B; Rémy V; Sainty D; Stoppa AM; Bernard P; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
Haematologica; 2007 Feb; 92(2):262-3. PubMed ID: 17296583
[TBL] [Abstract][Full Text] [Related]
11. RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.
Panagopoulos I; Fioretos T; Isaksson M; Mitelman F; Johansson B; Theorin N; Juliusson G
Genes Chromosomes Cancer; 2002 Dec; 35(4):372-4. PubMed ID: 12378533
[No Abstract] [Full Text] [Related]
12. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.
Gervais C; Murati A; Helias C; Struski S; Eischen A; Lippert E; Tigaud I; Penther D; Bastard C; Mugneret F; Poppe B; Speleman F; Talmant P; VanDen Akker J; Baranger L; Barin C; Luquet I; Nadal N; Nguyen-Khac F; Maarek O; Herens C; Sainty D; Flandrin G; Birnbaum D; Mozziconacci MJ; Lessard M;
Leukemia; 2008 Aug; 22(8):1567-75. PubMed ID: 18528428
[TBL] [Abstract][Full Text] [Related]
13. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
[TBL] [Abstract][Full Text] [Related]
14. Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia.
Murati A; Adélaïde J; Mozziconacci MJ; Popovici C; Carbuccia N; Letessier A; Birg F; Birnbaum D; Chaffanet M
Br J Haematol; 2004 Jun; 125(5):601-4. PubMed ID: 15147375
[TBL] [Abstract][Full Text] [Related]
15. Identification of the MYST3-CREBBP fusion gene in infants with acute myeloid leukemia and hemophagocytosis.
Andrade FG; Noronha EP; Baseggio RM; Fonseca TC; Freire BM; Quezado Magalhaes IM; Zalcberg IR; Pombo-de-Oliveira MS
Rev Bras Hematol Hemoter; 2016; 38(4):291-297. PubMed ID: 27863755
[TBL] [Abstract][Full Text] [Related]
16. Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
Vizmanos JL; Larráyoz MJ; Vázquez I; Odero MD; Hernández R; Lahortiga I; Novo FJ; Ardanaz MT; Calasanz MJ
Cancer Genet Cytogenet; 2004 Jul; 152(2):177-8. PubMed ID: 15262444
[No Abstract] [Full Text] [Related]
17. t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.
Vizmanos JL; Larráyoz MJ; Lahortiga I; Floristán F; Alvarez C; Odero MD; Novo FJ; Calasanz MJ
Genes Chromosomes Cancer; 2003 Apr; 36(4):402-5. PubMed ID: 12619164
[TBL] [Abstract][Full Text] [Related]
18. t(8;16)(p11;p13) predisposes to a transient but potentially recurring neonatal leukemia.
Wong KF; Yuen HL; Siu LL; Pang A; Kwong YL
Hum Pathol; 2008 Nov; 39(11):1702-7. PubMed ID: 18657848
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ
Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous remission of adult acute myeloid leukemia with t(8;16)(p11;p13)/MOZ-CBP fusion.
Hoshino T; Taki T; Takada S; Hatsumi N; Sakura T
Leuk Lymphoma; 2018 Jan; 59(1):253-255. PubMed ID: 28535725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
